{"product_id":"scripps-cardiovascular-atherosclerosis","title":"Scripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2022","description":"\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003cbr\u003e\u003cbr\u003eScripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2022 Atherosclerotic cardiovascular disease is a common problem which may begin early in life and progress as a person ages.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e Include: 14 videos + 1 pdf, size: 3.08 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: cardiologists, endocrinologists, internists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eScripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2022 Atherosclerotic cardiovascular disease is a common problem which may begin early in life and progress as a person ages.\u003cbr\u003e\u003cbr\u003eThe atherosclerotic condition involves lipid deposition of the arterial wall, which involves the immune system, inflammatory mediators, and the endothelial system. Over time, if developing atherosclerosis is left untreated, it may be progressive and can result in several dangerous and life-threatening cardiovascular conditions including myocardial infarction, carotid artery disease and stroke, among others. While atherosclerosis can often be prevented through good lifestyle choices including proper diet and exercise, a number of therapeutic options are available for patients where lifestyle changes may not be enough.\u003cbr\u003e\u003cbr\u003eOver the past several years there has been a substantial increase of clinical trials specifically dedicated to the management and treatment of atherosclerosis and underlying risk factors. These studies have generated comprehensive data on a large number of randomized patients and have led to new indications for medical therapies. Clinicians need to be familiar with these evolving clinical diagnoses and novel therapeutic options for their patients.\u003cbr\u003e\u003cbr\u003eThe Scripps Cardiovascular Atherosclerosis conference is designed to offer a comprehensive summary of these new treatment options as well as to promote clinical awareness regarding prudent lifestyle and dietary choices to improve patient outcomes.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003eAfter attending this live internet activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify cardiac risk factors and estimation of patients’ clinical risk.\u003c\/li\u003e\n\u003cli\u003eExplain mechanism and indication of PCSK9 inhibitors and omega 3 fish oil.\u003c\/li\u003e\n\u003cli\u003eSummarize mechanism and indication of SGL2 inhibitors as well as GLP1 agonists’ mechanisms of action and cite indications for use.\u003c\/li\u003e\n\u003cli\u003eDescribe the cardiovascular benefits associated with diet and exercise modifications.\u003c\/li\u003e\n\u003cli\u003eAssess cardiac CT scoring and utility of coronary CTA.\u003c\/li\u003e\n\u003cli\u003eIllustrate polygenetic risk scoring in primary prevention of atherosclerotic cardiovascular disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiologists\u003c\/li\u003e\n\u003cli\u003eEndocrinologists\u003c\/li\u003e\n\u003cli\u003eInternists\u003c\/li\u003e\n\u003cli\u003eGeneral Practitioners\u003c\/li\u003e\n\u003cli\u003eNurses, Nurse Practitioners, Physician Assistants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAtherosclerosis is Inflammatory-Douglas Triffon, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCardiodiabetology- Expanding Your Specialty -Samantha Harris, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualization- Where Are We At- — Matthew Budoff, MD.mp4\u003c\/li\u003e\n\u003cli\u003eDietary Guidelines, Current Dietary Patterns and Cardiovascular Risk Association Sandeep Mehta, MD.mp4\u003c\/li\u003e\n\u003cli\u003eExercise and Sports Cardiology-Jeffrey Hsu, MD, MPH, PhD.mp4\u003c\/li\u003e\n\u003cli\u003eHormonal Influences on Vascular Disease-Poulina Uddin, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHow Do I Reverse Coronary Plaque-Christopher Suhar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHypertension Updates- Pharmacotherapies with A Focus on Clinical Cases-Luke Laffin, MD.mp4\u003c\/li\u003e\n\u003cli\u003eNon-statin Pharmacotherapies for Risk Reduction-Michael Wilkinson, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion_Q\u0026amp;A1.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion_Q\u0026amp;A2.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion_Q\u0026amp;A3.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Discussion_Q\u0026amp;A4.mp4\u003c\/li\u003e\n\u003cli\u003eSelect Dyslipidemia Cases David Cork, MD.mp4\u003c\/li\u003e\n\u003cli\u003eProgram.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954290364514,"sku":"MED-AMB00383","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-Cardiovascular-Atherosclerosis-Prediction-Prevention-and-Management-2022.jpg?v=1779370188","url":"https:\/\/meducourse.com\/products\/scripps-cardiovascular-atherosclerosis","provider":"Meducourse","version":"1.0","type":"link"}